Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741890
What this trial is testing
ADAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)
Who this might be right for
Angina With Non-Obstructive Coronary Artery DiseaseCoronary Microvascular Dysfunction (CMD)
The Christ Hospital 120